Literature DB >> 15913478

Current Strategies in the management of Barrett's esophagus.

Kenneth K Wang1.   

Abstract

Barrett's esophagus has become a very important topic in gastroenterology. Its management may vary from essentially a surveillance strategy to highly invasive esophagectomy. The variation in management strategies has occurred because of the current perceptions regarding cancer risks, which range from almost negligible to an incidence of 30% in high-grade dysplasia. Although it is clear that most patients with Barrett's esophagus without dysplasia will not require therapy, the prospect of continued surveillance is unpleasant at best. Promising future tools and techniques for surveillance and treatment are described in this review.

Entities:  

Mesh:

Year:  2005        PMID: 15913478      PMCID: PMC2646413          DOI: 10.1007/s11894-005-0034-9

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  38 in total

1.  Local treatment of early cancer in short Barrett's esophagus by means of argon plasma coagulation: initial experience.

Authors:  A May; L Gossner; E Günter; M Stolte; C Ell
Journal:  Endoscopy       Date:  1999-08       Impact factor: 10.093

2.  Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma.

Authors:  J L Van Laethem; R Jagodzinski; M O Peny; M Cremer; J Devière
Journal:  Endoscopy       Date:  2001-03       Impact factor: 10.093

3.  Endoscopic mucosal resection using a cap: techniques for use and preventing perforation.

Authors:  H Inoue; T Kawano; M Tani; K Takeshita; T Iwai
Journal:  Can J Gastroenterol       Date:  1999 Jul-Aug       Impact factor: 3.522

Review 4.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

Authors:  N J Shaheen; M A Crosby; E M Bozymski; R S Sandler
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

5.  Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus.

Authors:  C Ell; A May; L Gossner; O Pech; E Günter; G Mayer; R Henrich; M Vieth; H Müller; G Seitz; M Stolte
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

6.  Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy.

Authors:  K K Krishnadath; K K Wang; K Taniguchi; T J Sebo; N S Buttar; M A Anderson; L S Lutzke; W Liu
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

7.  Evaluation of endoscopic mucosal resection for superficial esophageal carcinoma.

Authors:  H Noguchi; Y Naomoto; H Kondo; M Haisa; T Yamatsuji; K Shigemitsu; H Aoki; H Isozaki; N Tanaka
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2000-12       Impact factor: 1.719

Review 8.  Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy.

Authors:  H Barr
Journal:  Gastrointest Endosc Clin N Am       Date:  2000-07

9.  Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus.

Authors:  P K Nijhawan; K K Wang
Journal:  Gastrointest Endosc       Date:  2000-09       Impact factor: 9.427

10.  Minimally invasive esophagectomy.

Authors:  J D Luketich; P R Schauer; N A Christie; T L Weigel; S Raja; H C Fernando; R J Keenan; N T Nguyen
Journal:  Ann Thorac Surg       Date:  2000-09       Impact factor: 4.330

View more
  2 in total

1.  Flexible miniature compound lens design for high-resolution optical coherence tomography balloon imaging catheter.

Authors:  Henry L Fu; Yuxin Leng; Michael J Cobb; Kevin Hsu; Joo Ha Hwang; Xingde Li
Journal:  J Biomed Opt       Date:  2008 Nov-Dec       Impact factor: 3.170

Review 2.  Chemoprevention in Barrett's esophagus.

Authors:  Sumera Ilyas; Cathrine J DeMars; Navtej S Buttar
Journal:  J Gastrointest Cancer       Date:  2007
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.